Hologic, Inc.
Clinical trials sponsored by Hologic, Inc., explained in plain language.
A medical technology company focused on women's health, including diagnostics and imaging.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study aims to sharpen breast cancer detection tech Results expected Nov 2026 (estimated)
- New mammogram tech put to the test in 7,500 women Results expected Nov 2026 (estimated)
-
New mammogram tech put to the test in 7,500 women
Diagnosis OngoingThis study is testing a new mammography device to see if it can safely produce clear images for breast cancer screening and diagnosis. About 7,500 women aged 35 and older who need a mammogram or breast biopsy will get an extra scan with the new device. The goal is to check image …
Sponsor: Hologic, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
New study aims to sharpen breast cancer detection tech
Knowledge-focused OngoingThis study collects contrast-enhanced mammogram images from 75 women aged 35+ who have a suspicious breast finding. The images will be used to improve software for future breast screening. Participants undergo standard diagnostic imaging or biopsy, but the study itself does not t…
Sponsor: Hologic, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC